
APYX Stock Forecast & Price Target
APYX Analyst Ratings
Bulls say
Apyx Medical is a growing company with a potential for significant market share in the expanding field of surgical aesthetics. Its products, such as Renuvion and AYON, offer cutting-edge technology that plastic surgeons and other physicians can use to achieve desired results for their patients. With a strong track record of financial growth and a strategic shift towards a more comprehensive platform approach, Apyx has the potential to continue its success and significantly increase its stock value.
Bears say
Apyx Medical is a relatively new company, having been founded in 1982. Although they offer innovative technologies in the cosmetic surgery market with their Renuvion platform and have expanded into international markets, market competition and negative financials could hinder the company's potential for growth and commercial success.
This aggregate rating is based on analysts' research of Apyx Medical Corp and is not a guaranteed prediction by Public.com or investment advice.
APYX Analyst Forecast & Price Prediction
Start investing in APYX
Order type
Buy in
Order amount
Est. shares
0 shares